Quantitative body mass characterization before and after head and neck cancer radiotherapy: A challenge of height-weight formulae using computed tomography measurement.

[1]  A. Garden,et al.  Association of Body Composition With Survival and Locoregional Control of Radiotherapy-Treated Head and Neck Squamous Cell Carcinoma. , 2016, JAMA oncology.

[2]  B. Strauss,et al.  Body composition analysis using abdominal scans from routine clinical care in patients with Crohn’s Disease , 2016, Scandinavian journal of gastroenterology.

[3]  V. Budach,et al.  Impact of weight loss on survival after chemoradiation for locally advanced head and neck Cancer: secondary results of a randomized phase III trial (SAKK 10/94) , 2014, Radiation oncology.

[4]  R. Wahl,et al.  Optimum Lean Body Formulation for Correction of Standardized Uptake Value in PET Imaging , 2014, The Journal of Nuclear Medicine.

[5]  J. Roodenburg,et al.  Validity of bioelectrical impedance analysis to assess fat‐free mass in patients with head and neck cancer: An exploratory study , 2014, Head & neck.

[6]  Sébastien Ourselin,et al.  Toward adaptive radiotherapy for head and neck patients: Feasibility study on using CT-to-CBCT deformable registration for "dose of the day" calculations. , 2014, Medical physics.

[7]  D. Rietveld,et al.  Critical weight loss is a major prognostic indicator for disease-specific survival in patients with head and neck cancer receiving radiotherapy , 2013, British Journal of Cancer.

[8]  L. Mccargar,et al.  Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  Katherine M Flegal,et al.  Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. , 2012, JAMA.

[10]  A. Nowacki,et al.  Understanding Equivalence and Noninferiority Testing , 2011, Journal of General Internal Medicine.

[11]  Lisa Martin,et al.  Sarcopenia in an Overweight or Obese Patient Is an Adverse Prognostic Factor in Pancreatic Cancer , 2009, Clinical Cancer Research.

[12]  Tony Reiman,et al.  A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. , 2008, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.

[13]  Tony Reiman,et al.  Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. , 2008, The Lancet. Oncology.

[14]  J. Krouwer.  Why Bland–Altman plots should use X, not (Y+X)/2 when X is a reference method , 2008, Statistics in medicine.

[15]  Stanley Heshka,et al.  Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image. , 2004, Journal of applied physiology.

[16]  K. Flegal,et al.  Criteria for definition of overweight in transition: background and recommendations for the United States. , 2000, The American journal of clinical nutrition.

[17]  S B Heymsfield,et al.  Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. , 1998, Journal of applied physiology.

[18]  Donald J. Schuirmann.  A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailability , 1987, Journal of Pharmacokinetics and Biopharmaceutics.

[19]  D. Altman,et al.  STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.

[20]  P. Boer.  Estimated lean body mass as an index for normalization of body fluid volumes in humans. , 1984, The American journal of physiology.

[21]  R Hume,et al.  Prediction of lean body mass from height and weight , 1966, Journal of clinical pathology.

[22]  S. Shapiro,et al.  An Analysis of Variance Test for Normality (Complete Samples) , 1965 .

[23]  A. Beckett,et al.  AKUFO AND IBARAPA. , 1965, Lancet.

[24]  C. Dunnett.  A Multiple Comparison Procedure for Comparing Several Treatments with a Control , 1955 .

[25]  Lisa Martin,et al.  Diagnostic criteria for the classification of cancer-associated weight loss. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  M. Sumi,et al.  Head and neck tumours: combined MRI assessment based on IVIM and TIC analyses for the differentiation of tumors of different histological types , 2013, European Radiology.

[27]  C. Ogden,et al.  Prevalence of Overweight, Obesity, and Extreme Obesity Among Adults: United States, Trends 1960-1962 Through 2009-2010 , 2012 .

[28]  L. Sjöström,et al.  Adipose tissue volume determinations in women by computed tomography: technical considerations. , 1986, International journal of obesity.

[29]  S. Heymsfield,et al.  Tissue components of weight loss in cancer patients. A new method of study and preliminary observations , 1985, Cancer.